|本期目录/Table of Contents|

[1]张金曼 综述,马勇杰,谷峰 审校.ITSN蛋白在肿瘤中的功能研究进展[J].天津医科大学学报,2019,25(06):662-665.
点击复制

ITSN蛋白在肿瘤中的功能研究进展(PDF)
分享到：

《天津医科大学学报》[ISSN:1006-8147/CN:12-1259/R]

卷:
25卷
期数:
2019年06期
页码:
662-665
栏目:
综述
出版日期:
2019-11-20

文章信息/Info

Title:
-
文章编号:
1006-8147(2019)06-0662-04
作者:
张金曼 综述; 马勇杰; 谷峰 审校
（天津医科大学肿瘤医院乳腺病理科，国家肿瘤临床医学研究中心，天津市“肿瘤防治”重点实验室，天津市恶性肿瘤临床医学研究中心，天津300060）
Author(s):
-
关键词:
ITSN; 肿瘤; 胞吞; 胞吐
Keywords:
-
分类号:
R730
DOI:
-
文献标志码:
A
摘要:
交叉蛋白Intersectin（ITSN）是一种具有多个结构域的细胞衔接蛋白，在细胞中能够参与多种信号通路，发挥不同的生物学功能。ITSN除了能在细胞的胞吞和胞吐、细胞肌动蛋白骨架重排、细胞内信号转导以及细胞的生存等方面起到调控的作用以外，还与许多人类疾病密切相关，尤其在肿瘤的发生发展以及迁移、侵袭过程中发挥着重要的作用。
Abstract:
-

参考文献/References:

[1] Tsyba L, Nikolaienko O, Dergai O, et al. Intersectin multidomain adaptor proteins: regulation of functional diversity[J]. Gene, 2011, 473(2):67
[2] Garcia E H, John P. Intersectin scaffold proteins and their role in cell signaling and endocytosis[J]. Biochim Biophys Acta, 2017, 1864(1):23
[3] Hunter M P, Nelson M, Kurzer M, et al. Intersectin 1 contributes to phenotypes in vivo: implications for Down Syndrome[J]. Neuroreport, 2011, 22(15):767
[4] O’Bryan J P. Intersecting pathways in cell biology[J]. Sci Signal, 2010, 3(152):re10
[5] Hunter M P, Russo A, O’Bryan J P. Emerging roles for intersectin (ITSN) in regulating signaling and disease pathways[J]. Int J Mol Sci, 2013, 14(4):7829
[6] Kropyvko S, Gryaznova T, Morderer D, et al. Mammalian verprolin CR16 acts as a modulator of ITSN scaffold proteins association with actin[J]. Bioch Biophys Res Commun, 2017, 484(4):813
[7] Kropyvko S, Gerasymchuk D, Skrypkina I, et al. Structural diversity and differential expression of novel human intersectin 1 isoforms[J]. Mol Biol Rep, 2010, 37(6): 2789
[8] Teckchandani A, Mulkearns E E, Randolph T W, et al. The clathrin adaptor Dab2 recruits EH domain scaffold proteins to regulate integrin beta1 endocytosis[J]. Mol biol cell, 2012, 23(15):2905
[9] Wong K A, Wilson J, Russo A, et al. Intersectin (ITSN) family of scaffolds function as molecular hubs in protein interaction networks[J]. PLoS One, 2012, 7(4):e36023
[10] Wong K A, Russo A, Wang X, et al. A new dimension to Ras function: a novel role for nucleotide-free Ras in Class II phosphatidylinositol 3-kinase beta (PI3KC2beta) regulation[J]. PLoS One, 2012, 7(9):e45360
[11] Frosi Y, Anastasi S, Ballaro C, et al. A two-tiered mechanism of EGFR inhibition by RALT/MIG6 via kinase suppression and receptor degradation[J]. J Cell Biol, 2010, 189(3):557
[12] Okur M N, Russo A, O’Bryan J P. Receptor tyrosine kinase ubiquitylation involves the dynamic regulation of Cbl-Spry2 by intersectin 1 and the Shp2 tyrosine phosphatase[J]. Mol Cell Biol, 2014, 34(2):271
[13] Zhang W, Shen Y, Xiong G, et al. Crystal structure of human Intersectin-2L C2 domain[J]. Biochem Biophys Res Commun, 2013, 431(1):76
[14] Gu F, Zhang H, Qin F, et al. Intersectin1-S, a multidomain adapter protein, is essential for malignant glioma proliferation[J]. Glia, 2015, 63(9):1595
[15] Russo A’O’Bryan J P. Intersectin 1 is required for neuroblastoma tumorigenesis[J]. Oncogene, 2012, 31(46):4828
[16] Louis C U, Shohet J M. Neuroblastoma: molecular pathogenesis and therapy[J]. Annu Rev Med, 2015, 66(1):49
[17] Pugh T J, Morozova O, Attiyeh E F, et al. The genetic landscape of high-risk neuroblastoma[J]. Nat Genet, 2013, 45(3):279
[18] Hunter M P, Russo A, O’Bryan J P. Emerging roles for Intersectin (ITSN) in regulating signaling and disease pathways[J]. Int J Mol Sci, 2013, 14(4):7829
[19] Ma Y, Wang B, Li W, et al. Intersectin1-s is involved in migration and invasion of human glioma cells[J]. J Neurosci Res, 2011, 89(7):1079
[20] Jeganathan N, Predescu D, Zhang J. Rac1-mediated cytoskeleton rearrangements induced by intersectin-1s deficiency promotes lung cancer cell proliferation, migration and metastasis[J]. Molecular Cancer, 2016, 15(1):59
[21] Pinon P, WehrleHaller B. Integrins: versatile receptors controlling melanocyte adhesion, migration and proliferation[J]. Pigment Cell Melanoma Res, 2011, 24(2):282
[22] Caswell P T, Vadrevu S, Norman J C. Integrins: Masters and slaves of endocytic transport[J]. Nat Rev Mol Cell Biol, 2009, 10(12):843
[23] De Franceschi N, Hamidi H, Alanko J, et al. Integrin traffic-The update[J]. J Cell Sci, 2015, 128(5):839
[24] Henne W M, Boucrot E, Meinecke M, et al. FCHo proteins are nucleators of clathrin-mediated endocytosis[J]. Science, 2010, 328(5983):1281
[25] Mayers J R, Wang L, Pramanik J, et al. Regulation of ubiquitin-dependent cargo sorting by multiple endocytic adaptors at the plasma membrane[J]. Proc Natl Acad Sci U S A, 2013, 110(29):11857
[26] Sundborger A C, Hinshaw J E. Regulating dynamin dynamics during endocytosis[J]. F1000 Prime Rep, 2014, 6:85
[27] Tsyba L, Nikolaienko O, Dergai O, et al. Intersectin multidomain adaptor proteins: regulation of functional diversity[J]. Gene, 2011, 473(2):67
[28] Gubar O, Morderer D, Tsyba L, et al. Intersectin: the crossroad between vesicle exocytosis and endocytosis[J]. Front Endocrinol (Lausanne), 2013, 4:109
[29] Koutros S, Schumacher F R, Hayes R B, et al. Pooled analysis of phosphatidylinositol 3-kinase pathway variants and risk of prostate cancer[J]. Cancer Res, 2010, 70(6):2389
[30] Boller D, Doepfner K T, de Laurentiis A, et al. Targeting PI3KC2beta impairs proliferation and survival in acute leukemia, brain tumours and neuroendocrine tumours[J]. Anticancer Re, 2012, 32(8):3015

相似文献/References:

[1]孙亚军,傅正,朱志峰,等.基因芯片分析三肽化合物酪丝亮肽对人肝癌基因表达谱的影响[J].天津医科大学学报,2013,19(05):353.
[2]王 勇,陈雅婧 综述,岳 丹审校.YB-1对肿瘤增殖调控的研究进展[J].天津医科大学学报,2014,20(04):332.
[3]叶剑飞 综述. microRNAs与肿瘤研究的新进展[J].天津医科大学学报,2014,20(05):416.
[4]孙秀梅,张 飞 综 述,牛瑞芳 审校. Nanog及其假基因NanogP8在肿瘤中的研究进展[J].天津医科大学学报,2015,21(03):90.
[5]孙秀梅,张 飞 综 述,牛瑞芳 审校. Nanog及其假基因NanogP8在肿瘤中的研究进展[J].天津医科大学学报,2015,21(01):90.
[6]黄 纯 综述,李 凯 审校. 肿瘤免疫治疗与化疗的协同效应研究现状[J].天津医科大学学报,2015,21(04):363.
[7]孔令平,周 旋 综述,张 仑 审校.长链非编码RNA MALAT1在肿瘤中的研究进展[J].天津医科大学学报,2015,21(04):367.
[8]郭小凡 综述,邓靖宇,梁 寒 审校.PCDH10启动子甲基化与恶性肿瘤关系的研究进展[J].天津医科大学学报,2016,22(02):182.
[9]姚庆娟 综 述,孙龙昊,何向辉 审 校.自噬对肿瘤免疫微环境的调控作用及其相关治疗策略[J].天津医科大学学报,2019,25(02):180.
[10]王 玲 综 述,徐燕颖 审 校.自然杀伤细胞表面NKp30受体的研究进展[J].天津医科大学学报,2019,25(05):544.

备注/Memo

备注/Memo:
基金项目 国家自然科学基金资助项目(81572851)
作者简介 张金曼（1993-），女，硕士在读，研究方向：生物化学与分子生物学；通信作者：谷峰，E-mail：fenggumayo@163.com。
更新日期/Last Update: 2020-01-20